Cancer Therapy: Dual Intratumoral Redox/Enzyme-Responsive NO-Releasing Nanomedicine for the Specific, High-Efficacy, and Low-Toxic Cancer Therapy (Adv. Mater. 30/2018)
Advanced Materials - United States
doi 10.1002/adma.201870217
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Wiley